Gene editing technology developer Metagenomi advances research from UC Berkeley and has raised a series A co-led by Bayer.

Gene editing technology developer Metagenomi closed its first round since emerging from stealth, with Leaps by Bayer the co-lead.

MultiCare Health System was among the investors in a round that took the telehealthcare provider's overall funding past the $50m mark.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Co-founded by a team of doctors and computer scientists out of Harvard Innovation Labs, Buoy Health has grown its overall financing to $66.5m.

Boston Children’s Hospital is the 18th university or research institute to receive academic bridge funding from Deerfield Management.

Partly based on University of Bern research, Synendos aims to restore the endocannabinoid system to treat dysfunction in the central nervous system.

The healthcare navigation software provider closed a $37.5m round co-led by Cigna Ventures and Humana and backed by Optum Ventures.

Sinopharm Capital and the WuXi AppTec-backed 6 Dimensions Capital are among the investors in the inflammatory and autoimmune disease drug developer.